|

CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer

RECRUITINGSponsored by Tel-Aviv Sourasky Medical Center
Actively Recruiting
SponsorTel-Aviv Sourasky Medical Center
Started2024-09-03
Est. completion2024-09-04
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06656728

Summary

The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information
2. Willing and able to sign an informed consent
3. Age ≥40 years

Exclusion Criteria:

1. Age \< 40 years
2. Pregnancy or breastfeeding
3. Any type of fever
4. Any cancer active at study entry or up to 5 years prior to study entry
5. Polyposis syndromes
6. Inflammatory bowel disease
7. Unwilling or unable to provide informed consent

Conditions2

CancerEarly Detection of Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.